Allarity Therapeutics Inc. (NASDAQ: ALLR)
$0.20
+0.0040 ( +2.04% ) 3.0M
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Market Data
Open
$0.20
Previous close
$0.20
Volume
3.0M
Market cap
$5.09M
Day range
$0.18 - $0.20
52 week range
$0.18 - $69.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Mar 26, 2024 |
8-k | 8K-related | 16 | Mar 20, 2024 |
8-k | 8K-related | 16 | Mar 15, 2024 |
8-k | 8K-related | 16 | Mar 08, 2024 |
10-k | Annual reports | 128 | Mar 08, 2024 |
def | Proxies and info statements | 6 | Mar 08, 2024 |
8-k | 8K-related | 14 | Mar 04, 2024 |
8-k | 8K-related | 32 | Mar 01, 2024 |
8-k | 8K-related | 17 | Feb 14, 2024 |
8-k | 8K-related | 15 | Feb 01, 2024 |